John Vavricka

Chief Commercial Officer, Atea Pharmaceuticals, Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jan 31, 2026Shares withheld for tax 11,570 shares at $4.24 of Atea Pharmaceuticals, Inc.²
Jan 31, 2026Exercised options 42,083 shares of Atea Pharmaceuticals, Inc.²
Jan 31, 2025Shares withheld for tax 11,517 shares at $3.06 of Atea Pharmaceuticals, Inc.³
Jan 31, 2025Granted 8,750 shares of Atea Pharmaceuticals, Inc.³
Jan 31, 2025Exercised options 33,333 shares of Atea Pharmaceuticals, Inc.³
Feb 1, 2024Sold 11,819 shares at $3.84 of Atea Pharmaceuticals, Inc.⁴
Jan 31, 2024Exercised options 33,334 shares of Atea Pharmaceuticals, Inc.⁴

The numbers on this page point here. Each one links to the record it came from.